Eur J Heart Fail. 2014 Apr;16(4):461-9. doi: 10.1002/ejhf.57.
The HEart function Assessment Registry Trial in Saudi Arabia (HEARTS) is a national multicentre project, studying clinical features, management, short- and long-term outcomes, and mortality predictors in patients admitted with acute decompensated heart failure (ADHF).
Our prospective registry enrolled 2610 ADHF patients admitted to 18 hospitals in Saudi Arabia between October 2009 and December 2010, and followed mortality rates until January 2013. The patients included 66% men and 85.5% Saudis, with a median age (interquartile range) of 61.4 (15) years; 64% had acute on chronic heart failure (HF), 64.1% diabetes mellitus, 70.6% hypertension, and 55.7% CAD. Exacerbating factors for hospital admission included acute coronary syndromes (37.8%), infections (20.6%), non-compliance with low-salt diet (25.2%), and non-compliance with HF medications (20%). An LVEF<40% was found in 73%. In-hospital use of evidence-based medications was high. All-cause cumulative mortality rates at 30 days, 6 months, 1 year, 2 years, and 3 years were 8.3, 13.7, 19.5, 23.5, and 24.3%, respectively. Important independent predictors of mortality were history of stroke, acute on chronic HF, systolic blood pressure<90 mmHg upon presentation, estimated glomerular filtration rate<60 mL/min, and haemoglobin<10 g/dL.
Patients with ADHF in Saudi Arabia presented at a younger age and had higher rates of CAD risk factors compared with those in developed countries. Most patients had reduced LV systolic function, mostly due to ischaemic aetiology, and had poor long-term prognosis. These findings indicate a need for nationwide primary prevention and HF disease management programmes.
沙特阿拉伯的心脏功能评估登记试验(HEARTS)是一个全国性的多中心项目,研究急性失代偿性心力衰竭(ADHF)患者的临床特征、管理、短期和长期结局以及死亡率预测因素。
我们的前瞻性登记研究纳入了 2009 年 10 月至 2010 年 12 月期间在沙特阿拉伯 18 家医院住院的 2610 例 ADHF 患者,并随访死亡率直至 2013 年 1 月。患者包括 66%的男性和 85.5%的沙特人,中位年龄(四分位间距)为 61.4(15)岁;64%为急性加重慢性心力衰竭(HF),64.1%为糖尿病,70.6%为高血压,55.7%为 CAD。住院的加重因素包括急性冠状动脉综合征(37.8%)、感染(20.6%)、低盐饮食不依从(25.2%)和 HF 药物不依从(20%)。73%的患者左心室射血分数(LVEF)<40%。院内使用基于证据的药物的比例较高。30 天、6 个月、1 年、2 年和 3 年的全因累积死亡率分别为 8.3%、13.7%、19.5%、23.5%和 24.3%。死亡的重要独立预测因素是中风史、急性加重慢性 HF、就诊时收缩压<90mmHg、估算肾小球滤过率<60mL/min 和血红蛋白<10g/dL。
与发达国家相比,沙特阿拉伯的 ADHF 患者就诊时年龄更小,CAD 风险因素的发生率更高。大多数患者的左心室收缩功能降低,主要是由于缺血性病因,且长期预后不良。这些发现表明需要开展全国性的一级预防和 HF 疾病管理计划。